<ѻý>Novel Agent Lessens Mucositis in Head and Neck Cancersѻý> IV infusion could allow more patients to complete treatment regimen Jun 06, 2022
<ѻý>Tiragolumab Fails in Extensive-Stage Small Cell Lung Cancerѻý> No change in survival when combined with atezolizumab and chemotherapy Jun 06, 2022
<ѻý>Liquid Biopsy May Save Colon Cancer Patients From Chemoѻý> Circulating tumor DNA could determine who needs more therapy Jun 06, 2022
<ѻý>Endocrine Switch Plus Ribociclib Active in Post-CDK4/6 Inhibitor Progressionѻý> First randomized support for strategy in progressive metastatic HR+/HER2- breast cancer Jun 06, 2022
<ѻý>Myeloma Trial Supports 'Personalized Approach' to Upfront Transplantѻý> DETERMINATION confirms benefit in triple-therapy setting, but suggests timing can be tailored Jun 06, 2022
<ѻý>Complete Responses in 100% of dMMR Rectal Cancer With Neoadjuvant PD-1 Inhibitionѻý> Chemo, RT, surgery avoided in short-term follow-up but study population was small Jun 05, 2022
<ѻý>Trastuzumab Deruxtecan Ushers in New Treatment Era for HER2-Low Breast Cancerѻý> DESTINY-Breast04 extends agent's benefits to historically tough-to-treat disease Jun 05, 2022
<ѻý>Will High-Dose Ifosfamide Become the Go-To Therapy in Recurrent Ewing Sarcoma?ѻý> Data from European rEECur trial "are potentially practice changing," expert says Jun 05, 2022
<ѻý>Third-Line BTK Inhibitor Combo Doubles PFS in Follicular Lymphomaѻý> Significantly more responses, CRs with zanubrutinib-obinutuzumab versus anti-CD20 drug alone Jun 05, 2022
<ѻý>Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancerѻý> But benefit seems to be predominantly in patients with PI3K/AKT/PTEN pathway alterations Jun 05, 2022
<ѻý>Sacituzumab Govitecan Boosts PFS in Late-Line HR+/HER2- Metastatic Breast Cancerѻý> "This may be something that really changes the lives of these women for the better," expert says Jun 05, 2022
<ѻý>Immunotherapy Rechallenge in NSCLC Yields Overall Survival Boostѻý> Phase II trial sees "synergistic benefit" with checkpoint blockade and anti-angiogenesis Jun 04, 2022
<ѻý>IL-15 Agonist Impresses in Non-Muscle Invasive Bladder Cancerѻý> High response rate, 99%-100% cancer-specific survival at 2 years Jun 04, 2022
<ѻý>Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphomaѻý> Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
<ѻý>KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patientsѻý> Median survival surpasses 1 year in heavily pretreated population Jun 03, 2022
<ѻý>Bariatric Surgery Cuts Cancer Incidence, Death Riskѻý> Study looked at people with obesity who underwent two most popular procedures Jun 03, 2022
<ѻý>5-Year Interval for Cervical Cancer Screening Safe in HPV-Negative Womenѻý> U.K. study also supports accuracy of HPV testing versus cytology Jun 03, 2022
<ѻý>Colonoscopy With a Computer-Aided Device Boosted Adenoma Detectionѻý> Use of the device led to a 27% increase in adenomas per colonoscopy versus standard procedure Jun 03, 2022
<ѻý>Add-On Ibrutinib Boosts PFS in Untreated, Older Mantle-Cell Lymphoma Patientsѻý> BTK inhibitor plus chemoimmunotherapy increased progression-free survival by over 2 years Jun 03, 2022
<ѻý>Survival Bump With EGFR Inhibitor for KRAS Wild-Type Pancreatic Cancerѻý> But generalizability of "notable" Chinese study questioned Jun 03, 2022
<ѻý>AI Shows Promise in Predicting Optimal Margin Width for CRC Liver Metsѻý> A 7-mm margin width linked with prolonged survival Jun 02, 2022
<ѻý>Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancerѻý> More than half of everolimus-treated patients permanently discontinued treatment Jun 02, 2022
<ѻý>T-Cell Receptor Gene Therapy Shows Promise in Pancreatic Cancerѻý> Novel treatment targeting KRAS G12D expression induces deep and durable response Jun 01, 2022
<ѻý>FDA Pulls Lymphoma Approvals for PI3K Inhibitor Umbralisibѻý> Worse overall survival observed despite improvements in progression-free survival Jun 01, 2022
<ѻý>Doc Gets Prison for COVID 'Cure'; Proton Therapy Gold Rush; Blackfeet Opioid Crisisѻý> This past week in healthcare investigations Jun 01, 2022
<ѻý>Increased Public Assistance Tied to Better Cancer Survival in Black Patientsѻý> Disparity in 5-year OS declined by more than 40% with each 10% boost in public welfare spending May 31, 2022
<ѻý>Is U.S. 'Getting Its Money's Worth' When It Comes to Cancer Care?ѻý> Cost/mortality benefit pales in comparison with other high-income countries, according to study May 31, 2022
<ѻý>Prone Beats Supine Positioning for WBRT in Women With Large Breastsѻý> Prone position led to lower rates of moist desquamation May 27, 2022
<ѻý>Cancer Outcome Disparities Not Fully Explained by Race, Socioeconomic Factorsѻý> Worse 5-year OS in Hispanic children with high-risk neuroblastoma in adjusted analysis May 27, 2022
<ѻý>Unprecedented PFS Improvement in Relapsed Multiple Myelomaѻý> Three-year median with addition of isatuximab to proteasome inhibitor backbone May 26, 2022
<ѻý>Black Patients Often Never Given a Chance to Join Breast Cancer Trialsѻý> But survey finds several actionable findings that could boost enrollment May 26, 2022
<ѻý>COVID Increased Use of Telemedicine for Cancer Care, Though Not Equitablyѻý> Black, uninsured, non-urban patients less likely to use these services May 26, 2022
<ѻý>Just How Effective Is PSA Screening?ѻý> Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
<ѻý>Younger People More Likely to Undergo Colonoscopy After Guideline Changeѻý> But most colonoscopies still done in those ages 50-54 May 17, 2022
<ѻý>Mental Health Issues Common, Often Overlooked in Prostate Cancerѻý> More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
<ѻý>Urologists Are Helping Combat the Opioid Epidemic, Studies Suggestѻý> Three reports show success in reducing opioid prescribing May 16, 2022
<ѻý>Robotic Surgery Wins for Keeping Bladder Cancer Patients Alive, Out of Hospitalѻý> Approach bested open surgery in iROC trial, but is the difference clinically important? May 15, 2022
<ѻý>Combo Treatment Scores Big in BCG-Unresponsive Bladder Cancerѻý> Significantly durable response with VesAnktiva-Bacillus Calmette-Guérin duo May 15, 2022
<ѻý>Concerning Spike in Barrett's Esophagus, Esophageal Cancer in Middle-Age Adultsѻý> Should these patients undergo screening, especially if they have risk factors? May 15, 2022
<ѻý>Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancerѻý> Prescribing rate is half that of women with no breast cancer history May 13, 2022